![Jay Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Mitchell
Director Técnico/Científico/I+D en
CLIMB BIO, INC.
.
Perfil
Jay Mitchell is Vice President-Clinical Operations at Climb Bio, Inc. since 2024.
Education includes an undergraduate degree from the University of Memphis and an MBA from the University of Mississippi.
Cargos activos de Jay Mitchell
| Empresas | Cargo | Inicio |
|---|---|---|
| CLIMB BIO, INC. | Director Técnico/Científico/I+D | 01/07/2024 |
Formación de Jay Mitchell.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
25
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
University of Memphis
 University of Memphis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
 University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
- Bolsa de valores
- Insiders
- Jay Mitchell
